Negotiations to Settle Abilify Gambling Claims Continues in Federal MDL

In a recent court filing, parties involved in hundreds of federal Abilify gambling lawsuits report that negotiations for a global settlement are continuing, and indicate that a stipulation will be filed next week regarding “no pay” case, which would be excluded from any potential deal.

Bristol-Myers Squibb and Otsuka Pharmaceuticals currently face about 1,100 claims in the federal court system, each raising similar allegations that the drug makers failed to adequately warn consumers and the medical community about the risk that Abilify may cause sudden urges to gamble or engage in other destructive behavior.

Plaintiffs maintain that they would have avoided devastating Abilify gambling losses if warnings had been provided about the importance of monitoring for signs of uncontrollable urges to engage in impulsive behaviors.

Did You Know?

Millions of Philips CPAP Machines Recalled

Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.

Learn More

Given similar questions of fact and law, the litigation has been centralized in the Northern District of Florida before U.S. District Judge M. Casey Rodgers, who has been pushing the parties to negotiate Abilify settlements that would avoid the need for hundreds of individual cases to go before juries.

On June 5, attorneys for plaintiffs and the defendants issued a joint proposed agenda (PDF) for an upcoming case management conference that will be held on June 12, indicating that the parties continue to meet to create the framework for a global settlement to resolve the litigation.

In advance of the meeting next week, the parties indicate that they anticipate submitting a stipulation for consideration by the court about which categories of claims would not be resolved as part of the negotiations, known as “no pay” cases.

The discussions come after Judge Rodgers issued an order last month, giving the parties until September 2018 to finalize a framework for settling Abilify claims, which would avoid the need for additional cases to be scheduled for trial.

Judge Rodgers previously scheduled three cases for early trial dates, which were expected to begin on June 18, August 6 and August 27, to help the parties gauge how juries may respond to certain evidence and testimony that may be repeated throughout other claims. However, the parties reached an agreement to settle all three of those Abilify cases in late April.

As part of the coordinated pretrial proceedings before Judge Rodgers, if the parties fail to reach an agreement to settle Abilify claims, each of the individual cases may ultimately be remanded back to U.S. District Courts nationwide for separate trial dates in the future.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 2 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.